Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00297063
Status:
COMPLETED
Last Update Posted:
2022-11-18
First Post:
2006-02-24
Brief Title:
BRL49653C In Type 2 Diabetes -Comparison Study With Pioglitazone And Placebo By Monotherapy-
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline